Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ajinomoto Health & Nutrition North America is a leading provider of amino acid-based solutions and services for the pharmaceutical, biotechnology, and food industries. The company specializes in the production of high-purity, USP-grade amino acids and the development of advanced cell culture media under the CELLiST brand to support biopharmaceutical manufacturing. Through its Ajinomoto Bio-Pharma Services division, it operates as a comprehensive CDMO, offering expertise in small molecule manufacturing, peptide synthesis, and large molecule biologics. Additionally, the company provides specialized medical foods for individuals with rare metabolic disorders through its subsidiary, Cambrooke Therapeutics. By leveraging proprietary technologies such as the Corynex protein expression system and AJIPHASE synthesis, Ajinomoto supports the entire drug development lifecycle from pre-clinical stages to commercial production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ajinomoto Health & Nutrition North America.